Blood bank issues associated with red cell exchanges in sickle cell disease

Journal of Clinical Apheresis

Volumn 21, Issue 4, 2006, Pages 271-273

  Sarode, Ravindra ^a   Altuntas, Fevzi ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

Apheresis; Blood bank; Red blood cell; Red cell exchange; Sickle cell disease

Indexed keywords

ALLOANTIBODY; HEMOGLOBIN S; RHESUS D ANTIGEN;

ACUTE CHEST SYNDROME; AFRICAN AMERICAN; ANTIBODY PRODUCTION; APHERESIS; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD GROUP KELL SYSTEM; BLOOD GROUP RHESUS SYSTEM; CAUCASIAN; CYTAPHERESIS; ERYTHROCYTE TRANSFUSION; FEVER; HUMAN; OXYGEN TISSUE LEVEL; PHENOTYPE; RED CELL EXCHANGE; SICKLE CELL ANEMIA; STROKE;

2,3-DIPHOSPHOGLYCERATE; ADENOSINE TRIPHOSPHATE; AFRICAN AMERICANS; ANEMIA, SICKLE CELL; BLOOD BANKS; BLOOD DONORS; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD PRESERVATION; CELL SURVIVAL; COLD; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEMATOCRIT; HEMOGLOBIN, SICKLE; HUMANS; ISOANTIGENS; LEUKOCYTE REDUCTION PROCEDURES; OXYGEN; SOLUTIONS; TIME FACTORS;

EID: 33845956042     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20112     Document Type: Article

References (20)

1. Beutler E. The sickle cell diseases and related disorders. In: Beutler E, Lichtman M, Coller B, Kipps T, Seligsohn U, editors. Williams hematology, 6th ed. New York: McGraw-Hill; 2001. p. 581-605.
2. Wierenga KJ, Hambleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet 2001;357:680-683.
3. Petrides M. Special transfusion situations. In: Practical guideline to transfusion medicine. Petrides M, Stack G, editors. Bethesda, MD: AABB Press; 2001, p. 209-238.
4. Pepkowitz S. Red Cell exchange and other therapeutic alterations of red cell mass. In: McLeod BC, Price TH, Weinstein R, editors. Apheresis: principles and practice, 2nd ed. Bethesda, MD: AABB Press. 2003. p. 411-432.
5. Smith JW, Weinstein R, For the AHCKL. Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 2003;43:820-822.
6. McLeod BC. Introduction to the third special issue: clinical applications of therapeutic apheresis. J Clin Apheresis 2000;15: 1-5.
7. Beutler E. Preservation and clinical use of erythrocytes and whole blood. In: Beutler E, Lichtman M, Coller B, Kipps T, Seligsohn U, editors. Williams hematology, 6th ed. New York: McGraw-Hill. 2001. p. 1879-1892.
8. Pugh TM, Johnson ST, Curnes JS, Weber KM. Reducing red cell alloimmunization in patients with sickle cell disease: a 9 year follow-up (SP359 Abstract). Transfusion 2004;44(Suppl): 135A.
9. Valeri CR, Hirsch NM. Restoration in vivo of erythrocyte adenosine triphosphate, 2,3-diphosphoglycrate, potassium ion, and sodium ion concentrations following the transfusion of acid-citrate- dextrose- stored human red blood cells. J Lab Clin Med 1969;73:722-733.
10. Beutler E, Duron O. Effect of pH on preservation of red cell ATP. Transfusion 1965;5:17-24.
11. Card RT, Mohandas N, Mollison PL. Relationship of post-transfusion viability to deformability of stored red cells. Br J Haematol 1983;53:237-240.
12. Wolfe LC. The membrane and the lesions of storage in preserved red cells. Transfusion 1985;25:185-203.
13. Sestier C, Sabolovic D, Geldwerth D, Moumaris M, Roger J, Pons JN, Halbreich A. Use of annexin V-ferrofluid to enumerate erythrocytes damaged in various pathologies or during storage in vitro. CR Acad Sci 1995;318:1141-1146.
14. Beutler E, Wood L. The in vivo regeneration of red cell 2, 3-diphosphoglyceric acid (DPG) after transfusion of stored blood. J Lab Clin Med 1969;74:300-304.
15. Simon TL, Marcus CS, Myhre BA et al. Effects of AS-3 nutrient additive solution on 42 and 49 days of storage of red cells. Transfusion 1987;27:178-182.
16. Wood L, Beutler E. Temperature dependence of sodium-potassium activated erythrocyte adenosine triphosphatase. J Lab Clin Med 1967;70:287-294.
17. Davies SC, Olatunji PO. Blood transfusion in sickle cell disease. Vox Sang 1995;68:145-151.
18. Danielson CF. The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher 2002;6:24-31.
19. Myers L, Paranjape G, Anderson C, Matevosyan K, Rutherford C, Sarode R, Rogers ZR. Isovolemic hemodilution-red blood cell exchange (IHD-RBCX) is superior to red blood cell exchange (RBCX) in the management of Sickle Cell Disease (SCD) patients on hypertransfusion programs following cerebrovascular accident (CVA). Blood 2003;102:764a, Abstract 2820.
20. Heddle NM, Kelton JG. Febrile nonhemolytic transfusion reactions. In: Popovsky MA, editor. Transfusion reactions. Bethesda, MD: American Association of Blood Banks Press. 2001. p. 45-82.